Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategies.
Lu H, Hong T, Jiang Y, Whiteway M, Zhang S.
Adv Drug Deliv Rev. 2023 Aug;199:114960. doi: 10.1016/j.addr.2023.114960. Epub 2023 Jun 10.
PMID:37307922
Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2alpha signaling.
Wang X, Zhou S, Hu X, Ye C, Nie Q, Wang K, Yan S, Lin J, Xu F, Li M, Wu Q, Sun L, Liu B, Zhang Y, Yun C, Wang X, Liu H, Yin WB, Zhao D, Hang J, Zhang S, Jiang C, Pang Y.
Cell Host Microbe. 2024 Jun 12;32(6):964-979.e7. doi: 10.1016/j.chom.2024.04.017. Epub 2024 May 15.
PMID:38754418
The gut, the bad and the harmless: Candida albicans as a commensal and opportunistic pathogen in the intestine.
Prenatal maternal infection promotes tissue-specific immunity and inflammation in offspring.
Lim AI, McFadden T, Link VM, Han SJ, Karlsson RM, Stacy A, Farley TK, Lima-Junior DS, Harrison OJ, Desai JV, Lionakis MS, Shih HY, Cameron HA, Belkaid Y.
Science. 2021 Aug 27;373(6558):eabf3002. doi: 10.1126/science.abf3002.
PMID:34446580
Intestinal candidiasis: an uncommon cause of necrotizing enterocolitis (NEC) in neonates.
Parra-Herran CE, Pelaez L, Sola JE, Urbiztondo AK, Rodriguez MM.